These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 24908354)
1. The growth-inhibitory and apoptosis-inducing effect of deferoxamine combined with arsenic trioxide on HL-60 xenografts in nude mice. Yu R; Wang D; Ren X; Zeng L; Liu Y Leuk Res; 2014 Sep; 38(9):1085-90. PubMed ID: 24908354 [TBL] [Abstract][Full Text] [Related]
2. [The inhibition effect of DFO alone and in combination with ATO on xenograft tumor growth of HL-60 cells in nude mice and its possible mechanism]. Yu RH; Zeng L; Liu YF Zhonghua Xue Ye Xue Za Zhi; 2011 Jun; 32(6):363-7. PubMed ID: 21781490 [TBL] [Abstract][Full Text] [Related]
3. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells. Wang W; Adachi M; Zhang R; Zhou J; Zhu D Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982 [TBL] [Abstract][Full Text] [Related]
4. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model]. Lu J; Jin J; Xu WL Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):228-33. PubMed ID: 16624066 [TBL] [Abstract][Full Text] [Related]
5. Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. Canestraro M; Galimberti S; Savli H; Palumbo GA; Tibullo D; Nagy B; Guerrini F; Piaggi S; Cine N; Metelli MR; Petrini M Cancer Genet Cytogenet; 2010 Jun; 199(2):110-20. PubMed ID: 20471514 [TBL] [Abstract][Full Text] [Related]
6. [Mechanisms of arsenic trioxide induced tumor cell apoptosis in myelodysplastic syndrome mice model in vivo]. Lu J; Jin J Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):782-6. PubMed ID: 17229386 [TBL] [Abstract][Full Text] [Related]
7. [Effect of bortezomib used alone or in combination with arsenic trioxide on HL-60 cell xenograft in nude mice]. Li L; Meng FY; Fu YB; Cai YX; Sun QX Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1504-6. PubMed ID: 17959525 [TBL] [Abstract][Full Text] [Related]
8. Toward adjunctive therapy of acute myeloid leukemia: is it feasible? Diamantidis MD; Papaioannou M Leuk Res; 2014 Sep; 38(9):1016-7. PubMed ID: 25063523 [No Abstract] [Full Text] [Related]
9. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo. Shen L; Zhang G; Lou Z; Xu G; Zhang G BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727 [TBL] [Abstract][Full Text] [Related]
10. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide. Ning S; Knox SJ Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556 [TBL] [Abstract][Full Text] [Related]
11. Combination of arsenic trioxide and chemotherapy in small cell lung cancer. Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effect and mechanisms of arsenic trioxide on subcutaneously implanted human gastric cancer in nude mice. Wu DD; Xiao YF; Geng Y; Hou J Cancer Genet Cytogenet; 2010 Apr; 198(2):90-6. PubMed ID: 20362223 [TBL] [Abstract][Full Text] [Related]
13. ABT-737 synergizes with arsenic trioxide to induce apoptosis of gastric carcinoma cells in vitro and in vivo. Sun XP; Zhang X; He C; Qiao H; Jiang X; Jiang H; Sun X J Int Med Res; 2012; 40(4):1251-64. PubMed ID: 22971477 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration. Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284 [TBL] [Abstract][Full Text] [Related]
15. Cotylenin A and arsenic trioxide cooperatively suppress cell proliferation and cell invasion activity in human breast cancer cells. Kasukabe T; Okabe-Kado J; Kato N; Honma Y; Kumakura S Int J Oncol; 2015 Feb; 46(2):841-8. PubMed ID: 25405645 [TBL] [Abstract][Full Text] [Related]
16. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice. Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125 [TBL] [Abstract][Full Text] [Related]
17. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide. Chien CW; Yao JH; Chang SY; Lee PC; Lee TC Toxicol Appl Pharmacol; 2011 Nov; 257(1):59-66. PubMed ID: 21889949 [TBL] [Abstract][Full Text] [Related]
18. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice]. Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075 [TBL] [Abstract][Full Text] [Related]
19. Synergistic therapeutic effect of arsenic trioxide and radiotherapy in BALB/C nude mice bearing nasopharyngeal carcinoma xenografts. Xie LX; Lin XH; Li DR; Chen JY; Hong CQ; Du CW Exp Oncol; 2007 Mar; 29(1):45-8. PubMed ID: 17431388 [TBL] [Abstract][Full Text] [Related]
20. Tumor growth inhibition of metastatic nasopharyngeal carcinoma cell lines by low dose of arsenic trioxide via alteration of cell cycle progression and induction of apoptosis. Yeh KY; Chang JW; Li YY; Wang CH; Wang HM Head Neck; 2011 May; 33(5):734-42. PubMed ID: 20737493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]